Breast cancer is among the most frequent tumors worldwide and over 200,000 women will develop the disease in the United States in 2016 [1]. Breast cancer is a heterogeneous disease, clinically classified based on the presence of hormonal receptors for estrogen (ER) and progesterone (PR), and the expression/amplification status of the human epidermal growth factor receptor 2 (HER2) protein/oncogene [2].
from #AlexandrosSfakianakis via Alexandros G.Sfakianakis on Inoreader http://ift.tt/2jgHpBS
via IFTTT
Εγγραφή σε:
Σχόλια ανάρτησης (Atom)
Δημοφιλείς αναρτήσεις
-
Prof Stupp speaks with ecancer at AACR 2017 about developing treatments for glioblastoma, from temozolomide and chemotherapy to novel tumour...
-
A correct chromatin structure is important for cell viability and is tightly regulated by numerous factors. Human protein complex FACT (faci...
-
Many different quantitative techniques have been developed to either assess Environmental Justice (EJ) issues or estimate exposure and dose ...
-
Evidence-Based Medicine: Cleft Palate. Plast Reconstr Surg. 2017 Jan;139(1):191e-203e Authors: Woo AS Abstract LEARNING OBJECTIVES:...
-
Trends in Otolaryngology Consultation Patterns at an Academic Quaternary Care Center. JAMA Otolaryngol Head Neck Surg. 2017 Jan 05;: ...
-
Abstract An intriguing piece of evidence for the inflammatory story of type 2 diabetes has come to the light. A recent study by Okin and co...
-
Leddsmerter kan ha mange årsaker. Traumatiske, immunologiske og infeksiøse lidelser må vurderes. En god anamnese kan sette oss på rett spor...
-
Background: Triple-negative breast cancer (TNBC) has a poor prognosis because of frequent recurrence. Androgen receptor (AR) is involved in ...
-
January 2017 from #AlexandrosSfakianakis via Alexandros G.Sfakianakis on Inoreader http://ift.tt/1LM6Z5k via IFTTT
Δεν υπάρχουν σχόλια:
Δημοσίευση σχολίου